Malaria Research Program at CBER Studies to improve Blood Safety from the risk of transfusion- transmitted malaria, and malaria pathogenesis and control.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

FDA Workshop “Data and Data Needs to Advance Risk Assessment for Emerging Infectious Diseases for Blood and Blood Products” November 29, 2011, Gaithersburg.
Calcium dependent protein kinases and Malaria: Identification of chemical start point for drug discovery Symposium: Academic Drug Discovery: Challenges.
Up date on malaria vaccine
Biotechnology Chapter 11.
Update on West Nile virus and Blood Safety November 3, 2005 Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.
MALARIA History The disease How people get Malaria ( transmission) Symptoms and Diagnosis Treatment Preventive measures Where malaria occurs in the world.
Malaria  Malaria is a vector borne parasitic disease caused by the genus Plasmodium, affecting over 100 countries of the tropical and subtropical regions.
Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP 25 October 2013.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
An Overview of Mission-related Research Office of Blood Research and Review C.D. Atreya, Ph.D. Associate Director for Research OBRR, CBER BPAC, Dec
Outline Background on Malaria and Plasmodium life cycle. Gateway cloning and using Expression vectors. Immune system, reverse vaccinology, and antibody.
OCR AS Biology – F212 – Module 2 Food & Health. Learning ObjectivesSuccess Criteria  Understand the causes and means of transmission of malaria, HIV/AIDS.
Parasitic protozoa of human importance : Disease : Malaria Agent : Plasmodium 4 species Differential pathogenicity Vector-borne Apicomplexan inhabiting.
F INDINGS National Institutes of Health National Institute of General Medical Sciences Science Without Borders Geneticist Dyann Wirth: Understanding the.
Dengue Virus and Its Risk to the U.S. Blood Supply
Risk of Babesia Infection by Blood Transfusion and Potential Strategies for Donor Testing: Introduction Sanjai Kumar, PhD Division of Emerging and Transfusion-Transmitted.
1 Babesia BPAC: FDA Perspective Sanjai Kumar, PhD Division of Emerging and Transfusion- Transmitted Diseases Office of Blood Research and Review CBER,
Workshop Summary FDA Workshop on Testing for malarial Infections in Blood Donors Sanjai Kumar, Ph.D. Center for Biologics Evaluation and Research Food.
MALARIA, ROLE OF SEROLOGY: ELISA AND PCR
M ALARIA RESEARCH IN THE POST - GENOMIC ERA Presenter: Reihaneh Rabbany Presented in Bioinformatics Course (CMPUT 606), Instructed by Prof. Guohui Lin,
An important message to blood donors Please read this BEFORE you donate blood.
Division of Emerging and Transfusion Transmitted Diseases Bioterrorism Preparedness Initiatives Hira L. Nakhasi, Ph.D.
A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &
Influenza Vaccine Development
The Need for Organ Site Specific Cancer Research John T Isaacs Chemical Therapeutic Program Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Laboratory of Immunobiochemistry site visit Jay E. Slater, MD FDA/CBER/OVRR/DBPAP June 29, 2006.
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
Division of Hematology Basil Golding M.D. Division Director Site Visits 2010 Laboratories of Hemostasis, and Plasma Derivatives.
Molecular Interactions Involved In Erythrocyte Invasion By Malaria Parasite Thesis Submitted to Jawaharlal Nehru University for the Award of the Degree.
Standardisation of P. falciparum HBV, HCV and NAT Sally Baylis, NIBSC SoGAT XVIII.
BASIC FACTS ABOUT MALARIA n Four Plasmodium species cause human malaria: P. falciparum (the most virulent), P. vivax, P. malariae, and P. ovale. Human.
Genetically Modified Live Attenuated Parasites as Leishmania vaccines : Evaluation of Safety and Efficacy Hira Nakhasi, Ph.D. Director DETTD/OBRR/CBER/USFDA.
Recombinant DNA technology
National Institute of Pathology (ICMR)
P. falciparum Life Cycle & Pathogenesis of Malaria Miller et al., Nature  Molecular and genetic.
West Nile Virus: Pathogenesis and Diagnostic Tools Maria Rios, PhD - Senior Staff Fellow Laboratory of Molecular Virology DETTD/OBRR/CBER/FDA WNV epidemic.
Review of Site Visit Report Laboratory of Molecular Virology DETTD/OBRR/CBER March 18, 2005 Hira L. Nakhasi, Ph.D. Director, DETTD.
Parasitic protists of human importance : Disease : Malaria Agent : Plasmodium 4 species Differential pathogenicity Vector-borne Apicomplexan inhabiting.
Bioinformatics and Malaria: How can the computer help in vaccine and drug design against Malaria?
HIV-1 & HIV : Robert Gallo: HTLV-1/ lymphocytes 1978: Robert Gallo: HTLV-1/ lymphocytes of leukemia patients of leukemia patients HTLV :
A. Discovery of New Genes related to Leishmania Pathogenesis and as Biomarkers of Attenuation Using a Genomic Microarray B. Multiplex PCR Microarray Assay.
Learning Unit 2 Basic malaria epidemiology and transmission dynamics.
14. Immunodiagnosis, Immunotherapy & Vaccination 王 家 鑫, MD College of Veterinary Medicine.
Malaria pan-R Malaria cassette. Agenda Disease overview Infectious agents Diagnosis pan-R Malaria cassette: specifications Conclusion.
CBER Overview of Laboratory of Molecular Virology Indira Hewlett, Ph.D Laboratory Chief.
OCR AS Biology – F212 – Module 2 Food & Health. Starter Questions  Describe the differences between a parasite and a pathogen.  List two diseases caused.
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
Lecture 27,28,29,30: Parasitology 4 lectures titled L 27: Intestinal protozoa L 28: Blood and tissue protozoa L 29: Intestinal helminths 4 lectures titled.
Malaria.
CD47 modulates the phagocytic clearance and replication of Plasmodium yoelii malaria parasite Rajdeep Banerjee 1, Sanjay Khandelwal 2, Yukiko Kozakai 1,
MALARIA Seema Jain, MS4 6/9/16. BIOLOGY Female Anopheles mosquito is infected with malaria parasites. The mosquito acts as a vector, carrying disease.
department < clinical chemistry, microbiology and immunology >
Malaria: Plasmodium sp.
MALARIAL VACCINES.
REVOLUTiONiZiNG MALARiA VACCiNATiON
We expect selection to keep lethal recessive alleles low in frequency
Nathan Jones, Sheetij Dutta, David Lanar
Malaria Research in the Real World
مالاریا جنس پلاسمودیوم: مالاریا شایعترین بیماری انگلی دنیا است.
Viral Genetics.
Immunology & Public Health
Parasitism.
A new antivirulence approach against pathogenic bacteria
Apicomplexa: Plasmodium
MALARIA & TRAVEL MEDICINE
Housekeeping May 1st 31 field trip, transport yourself to the Shady Lakes, pm. PCR results gel is posted (report) This lecture paper discussion.
Malaria: New Vaccines for Old?
Improved performance with saliva and urine as alternative DNA sources for malaria diagnosis by mitochondrial DNA-based PCR assays  C. Putaporntip, P.
Reverse Vaccinology: Developing Vaccines in the Era of Genomics
Presentation transcript:

Malaria Research Program at CBER Studies to improve Blood Safety from the risk of transfusion- transmitted malaria, and malaria pathogenesis and control Scientific Site Visit Review Summary Sanjai Kumar, Ph.D. Division of Emerging and Transfusion Transmitted Diseases CBER, FDA

CBER Mission-Oriented obligations and research projects Blood safety from transfusion-transmitted malaria - Development of DNA and antibody based tests for blood donor screening Provide expertise for the review of malaria vaccine INDs - Studies on malaria biology, pathogenesis, vaccination and biomarkers of virulence and immunity Only malaria research program at CBER Malaria Program Members: Sanjai Kumar, Ph.D., Supervisory Biologist (PI) Hong Zheng, M.S., Biologist Victoria Majam, M.S., Biologist Babita Mahajan, Ph.D., Post doctoral Fellow

Transfusion transmitted malaria in the US cases per year. All four species of Plasmodium implicated - Approximately 50% of cases were caused by malaria naïve travelers 1995 to case per year. P. falciparum is the predominant species – Caused by donors born in a malaria endemic country There is no laboratory test to screen blood donors for malaria infections Blood safety is maintained by risk based deferral policy Loss of approximately 150, 000 donors each year US travelers: 28 million each year US immigrants: asymptomatic carriers

Laboratory tests to detect malaria parasite infections in blood donors DNA Test Nested PCR - QIAmp kit 2.4 parasites/ml of blood Could leave up to 1200 parasites in a unit of blood For P. vivax infectious dose is 10 infected RBC or 0.02 parasites/ml in a unit of blood Patient Sera No. of Positives P. falciparum4/4 P. vivax8/8 P. malariae2/2 P. ovale7/8 Normal Sera0/2 ELISA Reactivity with recombinant PfCSP, PfAMA-1, and PfMSP1 42 Three P. falciparum proteins can be used to detect antibodies to all four Plasmodium spp

Live Attenuated Malaria Vaccines and Biomarkers of Virulence and Efficacy R,TSS, the most successful recombinant malaria vaccine induced only 30% protection for a short duration Data from natural immunity, irradiated sporozoites and genetically attenuated sporozoites suggest that whole parasites are the most effective vaccines Current research trend suggests that several INDs based on live attenuated malaria vaccines will be submitted to FDA in the coming years A program to identify the molecules associated with parasite growth, and survival for targeted gene deletion to generate live attenuated vaccines To identify the biomarkers that could predict the virulence and efficacy of live attenuated vaccines

Blood Stage Schizonts Electroporation & Transformation In vivo selection of resistant parasites Genetically altered live attenuated malaria vaccines Gene KO strategy for Centrin P. falciparumP. berghei In vitro drug selection Genetic analysis and microarray Genetic analysis and microarray Attenuated Sporozoite

Genome-Wide Expression Profiling in Malaria infection Reveals Transcriptional Changes Associated with Lethal and Nonlethal Outcomes Identify a set of host biomarkers that distinguishes between lethal and non- lethal malaria infections Metabolic acidosis resulting from the accumulation of lactate is an important prognostic indicator for the severity of malaria. Increased activity in the glycolysis pathway is associated with pyruvate conversion to lactate In 17XL, all genes in the glycolysis pathway are upregulated during the entire course of infection

Summary A nested PCR that detects 2 P. falciparum parasites/ ml of blood and a pan-Plasmodium ELISA that recognizes all four species Identified P. falciparum parasite molecular factors and associated biological pathways induced in response to febrile temperatures Identified both host and parasite biomarkers that distinguish between virulent and non-virulent strains of malarias Future Directions DNA and antibody based tests for the detection of malaria parasites in blood donors Suitable molecules for targeted gene deletion to create growth deficient malaria parasites Genetically attenuated live malaria vaccines and their safety, efficacy and virulence profiling Biomarkers that could predict the safety and efficacy of attenauted malaria vaccines

Collaborations FDA Hira Nakhasi, Anangmuthu Selvapandian NIH Tom McCutchan WRAIR Chris Ockenhouse Virginia Tech Dharmendar Rathore NCBI Aravind Iyer